121 related articles for article (PubMed ID: 18673144)
1. Two-dimensional QSAR studies on arylpiperazines as high-affinity 5-HT(1A) receptor ligands.
Weber KC; Honório KM; Andricopulo AD; Da Silva AB
Med Chem; 2008 Jul; 4(4):328-35. PubMed ID: 18673144
[TBL] [Abstract][Full Text] [Related]
2. SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL.
Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
Eur J Pharm Sci; 2013 Feb; 48(3):532-41. PubMed ID: 23287365
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
[TBL] [Abstract][Full Text] [Related]
4. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.
Heinrich T; Böttcher H; Gericke R; Bartoszyk GD; Anzali S; Seyfried CA; Greiner HE; Van Amsterdam C
J Med Chem; 2004 Sep; 47(19):4684-92. PubMed ID: 15341484
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
[TBL] [Abstract][Full Text] [Related]
7. A chemometric study of the 5-HT(1A) receptor affinities presented by arylpiperazine compounds.
Weber KC; da Silva AB
Eur J Med Chem; 2008 Feb; 43(2):364-72. PubMed ID: 17562349
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
Asproni B; Pau A; Bitti M; Melosu M; Cerri R; Dazzi L; Seu E; Maciocco E; Sanna E; Busonero F; Talani G; Pusceddu L; Altomare C; Trapani G; Biggio G
J Med Chem; 2002 Oct; 45(21):4655-68. PubMed ID: 12361392
[TBL] [Abstract][Full Text] [Related]
9. Computational methods in determination of pharmacophore models of 5-HT(1A), 5-HT(2A) and 5-HT(7) receptors.
Bielenica A; Kozioł AE; Struga M
Mini Rev Med Chem; 2013 Jun; 13(7):933-51. PubMed ID: 23544602
[TBL] [Abstract][Full Text] [Related]
10. Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators.
Honorio KM; Garratt RC; Andricopulo AD
Bioorg Med Chem Lett; 2005 Jun; 15(12):3119-25. PubMed ID: 15893927
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationship study of new potent and selective antagonists at the 5-HT(1A) and adrenergic alpha(1d) receptors: Derivatives of spiroethyl phenyl(substituted)piperazine.
Sharma BK; Singh P; Sharma S
J Enzyme Inhib Med Chem; 2006 Oct; 21(5):601-7. PubMed ID: 17194034
[TBL] [Abstract][Full Text] [Related]
12. QSAR study on the affinity of some arylpiperazines towards the 5-HT1A/alpha1-adrenergic receptor using the E-state index.
Debnath B; Samanta S; Naskar SK; Roy K; Jha T
Bioorg Med Chem Lett; 2003 Sep; 13(17):2837-42. PubMed ID: 14611840
[TBL] [Abstract][Full Text] [Related]
13. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological evaluation of new arylpiperazines. 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-quinazolidin-4-one - a dual serotonin 5-HT(1A)/5-HT(2A) receptor ligand with an anxiolytic-like activity.
Bojarski AJ; Kowalski P; Kowalska T; Duszyńska B; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Bioorg Med Chem; 2002 Dec; 10(12):3817-27. PubMed ID: 12413835
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of S-(-)-2-[[4-(napht-1-yl)piperazin-1-yl]methyl]-1,4-dioxoperhydropyrrolo[1,2-a]pyrazine (CSP-2503) using computational simulation. A 5-HT1A receptor agonist.
López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Olivella M; Pardo L; Delgado M; Manzanares J; Fuentes JA
Bioorg Med Chem Lett; 2003 Apr; 13(8):1429-32. PubMed ID: 12668005
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT(1A)R agonists with selectivity over alpha1-adrenoceptors.
López-Rodríguez ML; Morcillo MJ; Fernández E; Benhamú B; Tejada I; Ayala D; Viso A; Campillo M; Pardo L; Delgado M; Manzanares J; Fuentes JA
J Med Chem; 2005 Apr; 48(7):2548-58. PubMed ID: 15801844
[TBL] [Abstract][Full Text] [Related]
17. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
[TBL] [Abstract][Full Text] [Related]
18. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore-based 3D QSAR studies on a series of high affinity 5-HT1A receptor ligands.
Weber KC; Salum LB; Honório KM; Andricopulo AD; da Silva AB
Eur J Med Chem; 2010 Apr; 45(4):1508-14. PubMed ID: 20133028
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationships for a series of selective estrogen receptor-beta modulators.
Salum LB; Polikarpov I; Andricopulo AD
SAR QSAR Environ Res; 2007; 18(7-8):711-27. PubMed ID: 18038369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
